CD19 and cancer: There was a reduction in the CD19+ B cell populations in the blood and the PSF by the cancer cells that was less pronounced than the reduction induced by the HFD; in contrast, the depletion of B cells in the OFB by the cancer cells was more prominent than the HFD-induced changes.